12-19439767-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_153207.5(AEBP2):āc.68G>Cā(p.Gly23Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000366 in 1,365,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_153207.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AEBP2 | ENST00000266508.14 | c.68G>C | p.Gly23Ala | missense_variant | 1/8 | 1 | NM_153207.5 | ENSP00000266508.9 | ||
AEBP2 | ENST00000398864.7 | c.68G>C | p.Gly23Ala | missense_variant | 1/9 | 1 | ENSP00000381840.3 | |||
AEBP2 | ENST00000541908.5 | c.-16-22743G>C | intron_variant | 3 | ENSP00000437983.1 | |||||
AEBP2 | ENST00000538425.5 | c.-16-22743G>C | intron_variant | 4 | ENSP00000444255.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000184 AC: 2AN: 108950Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 60734
GnomAD4 exome AF: 0.00000366 AC: 5AN: 1365196Hom.: 0 Cov.: 36 AF XY: 0.00000148 AC XY: 1AN XY: 673636
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.68G>C (p.G23A) alteration is located in exon 1 (coding exon 1) of the AEBP2 gene. This alteration results from a G to C substitution at nucleotide position 68, causing the glycine (G) at amino acid position 23 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at